wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38640422-8EA5093B-CFE5-428A-892F-07B8888D50D6
Q38640422-8EA5093B-CFE5-428A-892F-07B8888D50D6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38640422-8EA5093B-CFE5-428A-892F-07B8888D50D6
Chronic myeloid leukemia: Second-line drugs of choice.
P2860
Q38640422-8EA5093B-CFE5-428A-892F-07B8888D50D6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38640422-8EA5093B-CFE5-428A-892F-07B8888D50D6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
67eee066dda75611449c8b3e95463dd9ba1f0164
P2860
Imatinib mesylate dose escalation is associated with durable responses in patients with chronic myeloid leukemia after cytogenetic failure on standard-dose imatinib therapy.